Financhill
Buy
56

LAB Quote, Financials, Valuation and Earnings

Last price:
$2.00
Seasonality move :
15.27%
Day range:
$1.90 - $2.05
52-week range:
$1.21 - $3.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.58x
P/B ratio:
1.52x
Volume:
4.7M
Avg. volume:
1.9M
1-year change:
3.63%
Market cap:
$744.5M
Revenue:
$106.3M
EPS (TTM):
-$0.71

Earnings Data

Next earnings date for LAB
Feb 28
2025
Most recent earnings per share
-$0.07
Beat by $0.00
(Oct 30/2024)
Consensus Estimate
-$0.08
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LAB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $43M -- -- -$0.03 --
10/30/2024 Q3 $41M $45M -$0.07 -$0.08 $0.00
07/31/2024 Q2 $48.2M $37.2M -$0.12 -$0.07 -$0.05
05/08/2024 Q1 $46M $45.5M -$0.27 -$0.10 -$0.17
02/28/2024 Q4 $24.9M $28.2M -$0.25 -$0.13 -$0.12
11/07/2023 Q3 -- -- -$0.27 -$0.12 -$0.15
08/08/2023 Q2 -- -- -$0.22 -$0.10 -$0.12
05/09/2023 Q1 -- -- -$0.21 -- --
02/14/2023 Q4 -- -- -$0.26 -- --
11/08/2022 Q3 -- -- -$0.37 -- --
08/08/2022 Q2 -- -- -$0.82 -- --
05/05/2022 Q1 -- -- -$0.99 -- --
02/17/2022 Q4 -- -- -$0.12 -- --
09/30/2021 Q3 -- -- -$0.18 -- --
06/30/2021 Q2 -- -- -$0.23 -- --
03/31/2021 Q1 -- -- -$0.25 -- --
12/31/2020 Q4 -- -- -$0.24 -- --
09/30/2020 Q3 -- -- -$0.08 -- --
06/30/2020 Q2 -- -- -$0.18 -- --
03/31/2020 Q1 -- -- -$0.23 -- --
12/31/2019 Q4 -- -- -$0.18 -- --
09/30/2019 Q3 -- -- -$0.19 -- --
06/30/2019 Q2 -- -- -$0.20 -- --
03/31/2019 Q1 -- -- -$0.44 -- --
12/31/2018 Q4 -- -- -$0.36 -- --
09/30/2018 Q3 -- -- -$0.38 -- --
06/30/2018 Q2 -- -- -$0.42 -- --
03/31/2018 Q1 -- -- -$0.34 -- --
12/31/2017 Q4 -- -- -$0.27 -- --
09/30/2017 Q3 -- -- -$0.46 -- --
06/30/2017 Q2 -- -- -$0.58 -- --
03/31/2017 Q1 -- -- -$0.59 -- --
12/31/2016 Q4 -- -- -$0.61 -- --
09/30/2016 Q3 -- -- -$0.68 -- --
06/30/2016 Q2 -- -- -$0.64 -- --
03/31/2016 Q1 -- -- -$0.69 -- --
12/31/2015 Q4 -- -- -$0.45 -- --
09/30/2015 Q3 -- -- -$0.32 -- --
06/30/2015 Q2 -- -- -$0.53 -- --
03/31/2015 Q1 -- -- -$0.56 -- --
12/31/2014 Q4 -- -- -$0.39 -- --

Standard BioTools Earnings Questions

  • How Much did Standard BioTools Generate in Revenue Last Quarter?

    Standard BioTools reported $45M worth of top line sales in its most recent quarter.

  • Did Standard BioTools Beat Earnings Last Quarter?

    Standard BioTools announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.08 per share.

  • Is Standard BioTools Profitable?

    Standard BioTools reported $23.3M that represents $0.06 per share over the last quarter.

  • What is the Analyst Consensus for Standard BioTools EPS Next Year?

    Standard BioTools's earnings are forecast to decrease from -$0.94 per share to -$0.45 per share next year representing a decrease of -77.13%.

  • When is Standard BioTools's Earnings Date?

    Standard BioTools's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock